- Argentina
- Australia
- Austria
- Bangladesh
- Belgium
- Botswana
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Cuba
- Czech Republic
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Latvia
- Lebanon
- Lithuania
- Malaysia
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Senegal
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Vietnam
- Zimbabwe
Philippines Health News API
Get the live top health headlines from Philippines with our JSON API.
Get API key for the Philippines Health News APIAPI Demonstration
This example demonstrates the HTTP request to make and the JSON response you will receive when you use the news api to get the top headlines from Philippines.
GET
https://gnews.io/api/v4/top-headlines?country=ph&category=health&apikey=API_KEY
{
"totalArticles": 93510,
"articles": [
{
"id": "b8005e9c7bd4834a35d185db6a9a733a",
"title": "Japan audio lab creates buzz for music putting babies to sleep",
"description": "A Japanese institute that analyzes audio for courtroom evidence has found viral success with musical sounds it created to help put babies to sleep.",
"content": "A Japanese institute that analyzes audio for courtroom evidence has found viral success with musical sounds it created to help put babies to sleep.\nThe General Incorporated Association Institute of Audio Communication Laboratory Chiba developed the m... [1892 chars]",
"url": "https://globalnation.inquirer.net/328050/japan-audio-analysis-lab-creates-buzz-for-music-putting-babies-to-sleep",
"image": "https://globalnation.inquirer.net/files/2026/06/Japan-audio-analysis-lab-scaled.jpeg",
"publishedAt": "2026-06-21T04:44:00Z",
"lang": "en",
"source": {
"id": "1d828a1488600fee0696e9cae4ba7765",
"name": "Inquirer.net",
"url": "https://globalnation.inquirer.net"
}
},
{
"id": "7f96b8a2732dc6b3ab1d9ee31c80f866",
"title": "Longitudinal antibody profiling after dengue reveals distinct dynamics by antibody specificity over 18 months",
"description": "The four dengue virus serotypes (DENV1-4) co-circulate worldwide, posing major challenges for vaccine development. One key issue is that certain levels and subsets of cross-reactive antibodies have been associated with enhanced disease during subsequent infection with a different DENV serotype. To understand the heterogeneity of DENV antibody responses and delineate their distinct kinetics, we define the magnitude and kinetics of 84 antiviral antibody subsets (by isotype, subclass, antigen, and cross-reactivity) after primary versus secondary dengue, using longitudinal samples collected <1, 3, 6 and 18 months post-symptom onset from a pediatric hospital study in Nicaragua. Interestingly, we find that after primary infection, cross-reactive IgG antibody responses against the envelope protein rise, not wane, over time. Antibody kinetics vary by specificity as measured by homologous versus cross-reactive subsets, viral antigen, and subdomain of a single antigen. Further, a substantial fraction of subjects still have IgA, IgM, and IgG3 responses above the assay background at 18 months post-infection. Overall, we find that the cross-reactive subset of post-primary anti-DENV antibody responses demonstrates distinct kinetics from overall DENV-binding antibodies as well as from secondary immune responses, which has implications for the outcome of subsequent DENV infections. Longitudinal antibody profiling in a Nicaraguan pediatric dengue cohort shows that cross-reactive IgG against the envelope protein rises, not wanes, over 18 months post-primary infection, with antibody kinetics differing by viral protein and domain.",
"content": "The four dengue virus serotypes (DENV1-4) co-circulate worldwide, posing major challenges for vaccine development. One key issue is that certain levels and subsets of cross-reactive antibodies have been associated with enhanced disease during subsequ... [2037 chars]",
"url": "https://www.nature.com/articles/s41467-026-74406-0?error=cookies_not_supported&code=85a73f7f-7036-4961-8d7f-c912eebd21be",
"image": "https://www.nature.com/static/images/favicons/nature/favicon-48x48-b52890008c.png",
"publishedAt": "2026-06-21T00:44:09Z",
"lang": "en",
"source": {
"id": "7abf0df285fbe93cdccffcc7c4088737",
"name": "Nature",
"url": "https://www.nature.com"
}
},
{
"id": "a1972dea514ff6865282dc7c276d8e34",
"title": "PLHIVs Get Support For HPV Awareness, Prevention",
"description": "A total of 500 beneficiaries completed this June the three doses of HPV vaccination regimen prescribed for immunocompromised individuals.",
"content": "Hundreds of People Living with HIV (PLHIVs) have received support to boost awareness and prevention of Human Papillomavirus (HPV), a common sexually transmitted infection that could lead to various complications.\nMSD in the Philippines recently compl... [2491 chars]",
"url": "https://www.onenews.ph/articles/plhivs-get-support-for-hpv-awareness-prevention",
"image": "https://1cms-img.imgix.net/PLHIV-HPV-Awareness.png",
"publishedAt": "2026-06-20T18:11:15Z",
"lang": "en",
"source": {
"id": "b77604480ee97a0387e573cd3e8bb7af",
"name": "OneNews.PH",
"url": "https://www.onenews.ph"
}
}
]
}